MedTrace Logo

A Psychosocial Program Impact Evaluation in Jordan

NCT03012451 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 817

Last updated 2021-01-15

No results posted yet for this study

Summary

The study aims to deliver a robust pre-post evaluation of the wellbeing impacts of an innovative, brief, and scalable psychosocial intervention, delivered to refugee youth living in urban settlements in Jordan. The study was conducted using two waves of data collection: the first featured an intervention and a matched control group, the second featured a full randomized control trial.

Conditions

  • Stress, Psychological
  • Mental Health Impairment

Interventions

BEHAVIORAL

Advancing Adolescents

The "Advancing Adolescents" programme is a structured 8-week psychosocial intervention for adolescents in humanitarian crises, based on profound stress attunement processes. It features three elements that are widely viewed as important to support youth adjustment in contexts of complex emergencies: (i) safety: establishment of a 'safe space' within the community as a base for activities and site of protection; (ii) support: facilitation of social support and self-expression; and (iii) structured activities: access to scheduled group activities.

Sponsors & Collaborators

  • Queen Margaret University

    collaborator OTHER

  • University of Western Ontario, Canada

    collaborator OTHER

  • Harvard University

    collaborator OTHER

  • University of Florida

    collaborator OTHER

  • Yale University

    lead OTHER

Principal Investigators

  • catherine panter-brick, PhD · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2016-09-30
Completion
2017-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03012451 on ClinicalTrials.gov